- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02717390
Bright by Three (BB3) Effectiveness Study
November 2, 2020 updated by: University of Colorado, Denver
The Investigators propose to conduct a pragmatic randomized controlled trial of 350 one to four year old children and their caregivers to study the effectiveness of 1) the Bright By Three (BB3) intervention for promoting children's language and socio-emotional development and 2) a modified version of the Safe 'N Sound (SNS) intervention for reducing safety hazards and injuries.
The SNS intervention will serve as a control for the BB3 group and vice versa so that all study participants will receive a clinically meaningful intervention.
In collaboration with primary care clinics that serve low-income and minority children, the Investigators will recruit and randomize 350 twelve to fifteen month olds and their parents/caregivers to one of the two intervention arms and deliver the interventions over a 2 year period.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado AMC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 1 year (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Low-income (based on insurance status of child being Medicaid or CHIP),
- Lower educational level (less than college level education) parents of 12 to 15 month old children from the Rocky Mountain Youth Clinic and the Child Health Clinic who speak either English or Spanish or both and their 12-15 month old toddlers.
Exclusion Criteria:
- Parents with children born prior to 36 weeks gestation (premature infants)
- Children with chronic conditions known to affect neuro-development, such as trisomy 21, or
- Children who have a positive screen on the Children with Special Health Care Needs screener 57
- Parents who have already participated in the BB3 program
- Parents without access to a smart phone
- Parents who cannot read or converse in either English or Spanish
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Bright By Three (BB3) Intervention
The purpose of the BB3 intervention (annual home visit, written materials, and BB3 mobile application 'app') is to increase parental talking, reading, playing, and praise (TRPP) behaviors and improves children's social-emotional and language development at ages 2, 3, and 4 years
|
The purpose of the BB3 intervention (annual home visit, written materials, and BB3 mobile application 'app') is to increase parental talking, reading, playing, and praise (TRPP) behaviors and improves children's social-emotional and language development at ages 2, 3, and 4 years.
|
|
Active Comparator: Texts for Child Safety (TCS) Intervention
The purpose of the injury prevention arm is to reduce the prevalence of safety hazards in the home and car environments, decrease the number of self-reported and medically-attended injuries among children, and increase caregiver's self-reported safety behaviors and knowledge of child safety.
The Investigators will compare the results of our tailored child safety intervention (Texts for Child Safety [TCS]) among participants in the injury prevention arm with those randomized to the BB3 arm.
|
The purpose of the injury prevention arm is to reduce the prevalence of safety hazards in the home and car environments, decrease the number of self-reported and medically-attended injuries among children, and increase caregiver's self-reported safety behaviors and knowledge of child safety.
The Investigators will compare the results of our tailored child safety intervention (Texts for Child Safety [TCS]) among participants in the injury prevention arm with those randomized to the BB3 arm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in parental behavior based on the Stim-Q
Time Frame: Child ages 1, 2, 3 and 4
|
The Stim-Q assessment tool is a reliable and valid of the cognitive stimulation provided in the home for children between 5 months and 6 years old.
It can be completed by a parent in English or Spanish in about 20 minutes and has been used in several studies of interventions to support early childhood development
|
Child ages 1, 2, 3 and 4
|
|
Change in children's language development based on the CDI
Time Frame: Child ages 1 and 2.
|
The MacArthur-Bates Communicative Development Inventories (CDI)-Words and Gestures, Words and Sentences, and CDI-III forms are norm- referenced measures of children's language development that can be completed by a parent in English or Spanish in about 20 minutes for children 8 through 37 months of age.
|
Child ages 1 and 2.
|
|
Change in children's language development based on the E/ROWPVT-4
Time Frame: Child age 3.
|
The Receptive and Expressive One- Word Picture Vocabulary Tests (E/ROWPVT-4) are norm-referenced assessments used to assess receptive and expressive vocabulary skills in children ages 2 years and older who speak English or Spanish.
These tests can be administered in-person by a trained research assistant and each take about 20 minutes to complete.
Both the CDI and the E/ROWPVT have been used in studies of interventions for language development.
|
Child age 3.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parental attitudes, norms, self-efficacy, and intentions toward talking, reading, playing, praising (TRPP) behaviors
Time Frame: Child ages 1, 2 and 3
|
Measured by a survey similar to the one used in the pilot study - Survey developed by the study team based on the Theories of Planned Behavior and Social Cognitive Theory using measures on attitudes, norms, self-efficacy and intentions validated from other research as a template.
|
Child ages 1, 2 and 3
|
|
Parental positive regard for the children measured by the Parenting Stress Index
Time Frame: Child ages 1, 2 and 3
|
The Parenting Stress Index has been validated with diverse populations to identify dysfunctional parent-child systems in families with infants to 10 year old children, can be completed by a parent in English or Spanish in about 20 minutes, and has been used in hundreds of studies related to early childhood development
|
Child ages 1, 2 and 3
|
|
Children's socio-emotional development based on the Child Behavior Checklist
Time Frame: Child ages 2 and 3
|
The Child Behavior Checklist, Preschool is a validated, commonly used, parent completed tool to identify children ages 1.5 to 5 with emotional and behavioral problems
|
Child ages 2 and 3
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Mandy Allison, MD, MSPH, University of Colorado, Denver
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2017
Primary Completion (Actual)
March 30, 2019
Study Completion (Actual)
March 30, 2019
Study Registration Dates
First Submitted
March 15, 2016
First Submitted That Met QC Criteria
March 17, 2016
First Posted (Estimate)
March 23, 2016
Study Record Updates
Last Update Posted (Actual)
November 4, 2020
Last Update Submitted That Met QC Criteria
November 2, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 15-2164
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Developmental Delay
-
Tokat Gaziosmanpasa UniversityRecruiting
-
Florida Gulf Coast UniversityRecruitingDevelopmental DelayUnited States
-
Taipei Medical UniversityNot yet recruiting
-
Hacettepe UniversityCompleted
-
Salus UniversityActive, not recruitingDevelopmental DelayUnited States
-
Amar Seva SangamUniversity of Toronto; Grand Challenges CanadaCompleted
-
Children's Hospital Medical Center, CincinnatiOffice of Head StartCompleted
-
Texas Woman's UniversityCompleted
-
Taipei Medical UniversityShin Kong Wu Ho-Su Memorial HospitalUnknown
-
Chang Gung Memorial HospitalCompletedDevelopment and Effectiveness of Home-based Programs for Preschool Children With Developmental DelayDevelopmental DelayTaiwan
Clinical Trials on Bright By Three (BB3)
-
Case Western Reserve UniversityUniversity Hospitals Cleveland Medical CenterCompleted
-
University of Texas at AustinAmerican Diabetes AssociationActive, not recruitingMetabolic Syndrome | Infant Development | Infant Obesity | Diabetes Mellitus Risk | Infant Overnutrition | Infant OverweightUnited States
-
Chinese PLA General HospitalNot yet recruitingFracture of Neck of FemurChina
-
Erica OsbornTerminatedChronic Obstructive Pulmonary Disease | Depressive Symptoms | Cystic FibrosisUnited States
-
Chongqing University Cancer HospitalRecruitingOvarian CancerChina
-
Centre Hospitalier Universitaire de Saint EtienneCompletedPigmented Lesions | Genital TumorFrance
-
M.D. Anderson Cancer CenterCompletedLung CarcinomaUnited States
-
University of Roma La SapienzaRecruiting
-
Regionsenter for barn og unges psykiske helseNorwegian University of Science and Technology; The Research Council of Norway and other collaboratorsCompletedChild Development | Childcare QualityNorway
-
University of BaselUniversity of Geneva, SwitzerlandCompleted